About Windgap Medical
Windgap Medical is a Healthcare company based in Boston (United States) founded in 2011. Drug delivery autoinjectors for anaphylaxis treatment are provided. Windgap Medical has raised $76.71 million across 11 funding rounds from investors including Molex, Taiwania Capital and Shepherd Kaplan Krochuk. The company has 8 employees. Windgap Medical offers products and services including LVDC and ANDIPen®. Its focus areas include Life Sciences, Drug Delivery, Safe Syringes and Auto Injector. Its competitors include Xeris Pharmaceuticals, Qlibrium and Cellular Vehicles; 1 of its 3 listed competitors has raised funding.
Company details
Windgap Medical was founded in 2011 and is based in Boston, United States. Operations focus on the medical device sector, where autoinjectors for anaphylaxis treatment are developed and supplied. The ANDIPEN device, utilizing patent-pending microfluidics technology, delivers epinephrine as a temperature-insensitive and heat-stable option. This addresses needs in allergy management through reliable drug administration systems.
- Headquarters Boston, United States
- Employees 8
- SectorsHealthcare
- Website windgapmedical.com
- Social LinkedIn X
- Legal Name Windgap Medical
- Total Equity Funding$76.71M (USD)
in 11 rounds
- Latest Funding Round$12.65M (USD), Series B
Nov 2023
- InvestorsMolex
& 5 more
- Employee Count8
Products & Services of Windgap Medical
Windgap Medical offers a comprehensive portfolio of products and services, including LVDC and ANDIPen®.
Enables large volume injections up to 10 mL for complex drugs.
Supports sequential delivery of two liquid therapies through one needle.
Funding Insights of Windgap Medical
Windgap Medical has successfully raised a total of $76.71M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $12.65 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $76.71M
- Total Rounds 11
- Last Round Series B — $12.65M
- Investors Count 6
Latest 10 of 11 funding rounds of Windgap Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $12.65M | Series B | – | – | – |
| Sep 2021 | $39.15M | Series B | – | Taiwania Capital | |
| Mar 2020 | $360,500 | Series B | – | – | – |
| Jan 2019 | $12.15M | Series B | – | SKK | |
| Jul 2018 | $3.79M | Series A | – | – | – |
| Apr 2016 | $2.89M | Series A | – | – | – |
| Aug 2015 | $4.22M | Series A | – | – | – |
| May 2015 | $250,000 | Debt – Conventional | – | – | – |
| Dec 2014 | $999,696 | Grant | – | – | |
| Apr 2014 | $1.49M | Seed | – | – | – |
6 investors in total: 6 institutional.
Investors in Windgap Medical
Windgap Medical has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Molex, Taiwania Capital and Shepherd Kaplan Krochuk.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm focusing on technology companies | taiwaniacapital.com | Taipei, Taiwan | ||
| molexventures.com | ||||
Life sciences innovation is supported through funding and programs. | masslifesciences.com | Waltham, United States | ||
Early-stage entrepreneurs are accelerated through MassChallenge's program. | masschallenge.org | Boston, United States | ||
Shepherd Kaplan Krochuk is engaged in wealth and asset management. | skk-llc.com | Boston, United States | ||
Communication equipment manufacturer | 1938 | molex.com | Lisle, United States |
Investor details for Windgap Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Windgap Medical
7 people are tracked at Windgap Medical (3 in leadership, 4 in board & advisors); the tracked headcount is 8.
| Name | Role | Group |
|---|---|---|
Anthony W. | Vice President Regulatory Affairs And Quality | Leadership |
Max Meehan | VP Corporate Development & Finance | Leadership |
Brent Buchine | Chief Business Officer & Co-Founder | Leadership |
Rick Russell | Chairman | Board & advisors |
John Conley | Director | Board & advisors |
William McKee | Director | Board & advisors |
Tim Krochuk | Director | Board & advisors |
Complete people profiles for Windgap Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Windgap Medical
3 dated milestones of Windgap Medical across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Windgap Medical is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $12.7M.
Competitors of Windgap Medical
Windgap Medical has 3 listed competitors in our database, 1 of them funded. They include Xeris Pharmaceuticals, Qlibrium and Cellular Vehicles.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| xerispharma.com | 2005 | Chicago, United States | $110.43M | 294 | Liquid-stable injectables are developed for peptide and protein drug delivery. | |
| qlibriumlabs.com | 2014 | Woburn, United States | On-body drug delivery systems are developed using advanced microfluidic technology. | |||
| cellularvehicles.com | 2021 | San Mateo, United States | Cell-based therapeutics for blood-based diseases are developed and delivered locally. |
Detailed competitors of Windgap Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Windgap Medical (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Windgap Medical
Complete news archive for Windgap Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Windgap Medical
Windgap Medical was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Windgap Medical is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Windgap Medical is a funded company, having raised a total of $76.71M across 11 funding rounds to date. The company's 1st funding round was a Seed of $1.49M, raised on Jun 2012.
Windgap Medical has 8 employees.
Windgap Medical was founded in 2011 and is based in Boston, United States. Operations focus on the medical device sector, where autoinjectors for anaphylaxis treatment are developed and supplied. The ANDIPEN device, utilizing patent-pending microfluidics technology, delivers epinephrine as a temperature-insensitive and heat-stable option. This addresses needs in allergy management through reliable drug administration systems.
Windgap Medical's top competitors include Xeris Pharmaceuticals, Qlibrium and Cellular Vehicles.
Windgap Medical offers LVDC and ANDIPen®.
Windgap Medical has 6 investors. Key investors include Molex, Taiwania Capital, Shepherd Kaplan Krochuk, Molex Ventures, and Massachusetts Life Sciences Center.
Windgap Medical operates through Windgap Medical.